These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21773780)

  • 21. Expression of CXCR6 and its ligand CXCL16 in the lung in health and disease.
    Morgan AJ; Guillen C; Symon FA; Huynh TT; Berry MA; Entwisle JJ; Briskin M; Pavord ID; Wardlaw AJ
    Clin Exp Allergy; 2005 Dec; 35(12):1572-80. PubMed ID: 16393323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role for CXCR6 and its ligand CXCL16 in the pathogenesis of T-cell alveolitis in sarcoidosis.
    Agostini C; Cabrelle A; Calabrese F; Bortoli M; Scquizzato E; Carraro S; Miorin M; Beghè B; Trentin L; Zambello R; Facco M; Semenzato G
    Am J Respir Crit Care Med; 2005 Nov; 172(10):1290-8. PubMed ID: 16100013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CXCR6 upregulation contributes to a proinflammatory tumor microenvironment that drives metastasis and poor patient outcomes in hepatocellular carcinoma.
    Gao Q; Zhao YJ; Wang XY; Qiu SJ; Shi YH; Sun J; Yi Y; Shi JY; Shi GM; Ding ZB; Xiao YS; Zhao ZH; Zhou J; He XH; Fan J
    Cancer Res; 2012 Jul; 72(14):3546-56. PubMed ID: 22710437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and regulation of the chemokine CXCL16 in Crohn's disease and models of intestinal inflammation.
    Diegelmann J; Seiderer J; Niess JH; Haller D; Göke B; Reinecker HC; Brand S
    Inflamm Bowel Dis; 2010 Nov; 16(11):1871-81. PubMed ID: 20848509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of the CXCL16/CXCR6 Pathway by Inflammation Contributes to Atherosclerosis in Patients with End-stage Renal Disease.
    Hu ZB; Chen Y; Gong YX; Gao M; Zhang Y; Wang GH; Tang RN; Liu H; Liu BC; Ma KL
    Int J Med Sci; 2016; 13(11):858-867. PubMed ID: 27877078
    [No Abstract]   [Full Text] [Related]  

  • 26. Cell surface-anchored SR-PSOX/CXC chemokine ligand 16 mediates firm adhesion of CXC chemokine receptor 6-expressing cells.
    Shimaoka T; Nakayama T; Fukumoto N; Kume N; Takahashi S; Yamaguchi J; Minami M; Hayashida K; Kita T; Ohsumi J; Yoshie O; Yonehara S
    J Leukoc Biol; 2004 Feb; 75(2):267-74. PubMed ID: 14634054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-196b targets c-myc and Bcl-2 expression, inhibits proliferation and induces apoptosis in endometriotic stromal cells.
    Abe W; Nasu K; Nakada C; Kawano Y; Moriyama M; Narahara H
    Hum Reprod; 2013 Mar; 28(3):750-61. PubMed ID: 23293219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CXCL16 and CXCR6 in Ewing sarcoma family tumor.
    Na KY; Kim HS; Jung WW; Sung JY; Kalil RK; Kim YW; Park YK
    Hum Pathol; 2014 Apr; 45(4):753-60. PubMed ID: 24507753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The CXCL16-CXCR6 chemokine axis in glial tumors.
    Hattermann K; Held-Feindt J; Ludwig A; Mentlein R
    J Neuroimmunol; 2013 Jul; 260(1-2):47-54. PubMed ID: 23628207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CXCL16/SR-PSOX is an interferon-gamma-regulated chemokine and scavenger receptor expressed in atherosclerotic lesions.
    Wuttge DM; Zhou X; Sheikine Y; Wågsäter D; Stemme V; Hedin U; Stemme S; Hansson GK; Sirsjö A
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):750-5. PubMed ID: 14988089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of the CXCL12/CXCR4 and CXCL16/CXCR6 axes in cervical intraepithelial neoplasia and cervical cancer.
    Huang Y; Zhang J; Cui ZM; Zhao J; Zheng Y
    Chin J Cancer; 2013 May; 32(5):289-96. PubMed ID: 22958742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human trophoblasts recruited T lymphocytes and monocytes into decidua by secretion of chemokine CXCL16 and interaction with CXCR6 in the first-trimester pregnancy.
    Huang Y; Zhu XY; Du MR; Li DJ
    J Immunol; 2008 Feb; 180(4):2367-75. PubMed ID: 18250446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients.
    Gutwein P; Schramme A; Sinke N; Abdel-Bakky MS; Voss B; Obermüller N; Doberstein K; Koziolek M; Fritzsche F; Johannsen M; Jung K; Schaider H; Altevogt P; Ludwig A; Pfeilschifter J; Kristiansen G
    Eur J Cancer; 2009 Feb; 45(3):478-89. PubMed ID: 19070478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Irradiation of breast cancer cells enhances CXCL16 ligand expression and induces the migration of natural killer cells expressing the CXCR6 receptor.
    Yoon MS; Pham CT; Phan MT; Shin DJ; Jang YY; Park MH; Kim SK; Kim S; Cho D
    Cytotherapy; 2016 Dec; 18(12):1532-1542. PubMed ID: 27720639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CXCL16/CXCR6 chemokine signaling mediates breast cancer progression by pERK1/2-dependent mechanisms.
    Xiao G; Wang X; Wang J; Zu L; Cheng G; Hao M; Sun X; Xue Y; Lu J; Wang J
    Oncotarget; 2015 Jun; 6(16):14165-78. PubMed ID: 25909173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of the CXCL16/CXCR6 Axis by TNF-α Contributes to Ectopic Endometrial Stromal Cells Migration and Invasion.
    Peng Y; Ma J; Lin J
    Reprod Sci; 2019 Mar; 26(3):420-427. PubMed ID: 29779473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Down-regulation of interleukin-1 receptor type 1 expression causes the dysregulated expression of CXC chemokines in endometriotic stromal cells: a possible mechanism for the altered immunological functions in endometriosis.
    Nishida M; Nasu K; Fukuda J; Kawano Y; Narahara H; Miyakawa I
    J Clin Endocrinol Metab; 2004 Oct; 89(10):5094-100. PubMed ID: 15472211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CXCR6-CXCL16 interaction in the pathogenesis of Juvenile Idiopathic Arthritis.
    Martini G; Cabrelle A; Calabrese F; Carraro S; Scquizzato E; Teramo A; Facco M; Zulian F; Agostini C
    Clin Immunol; 2008 Nov; 129(2):268-76. PubMed ID: 18760678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Soluble CXCL16 in preoperative serum is a novel prognostic marker and predicts recurrence of liver metastases in colorectal cancer patients.
    Matsushita K; Toiyama Y; Tanaka K; Saigusa S; Hiro J; Uchida K; Inoue Y; Kusunoki M
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S518-27. PubMed ID: 21845497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High levels and inflammatory effects of soluble CXC ligand 16 (CXCL16) in coronary artery disease: down-regulatory effects of statins.
    Smith C; Halvorsen B; Otterdal K; Waehre T; Yndestad A; Fevang B; Sandberg WJ; Breland UM; Frøland SS; Oie E; Gullestad L; Damås JK; Aukrust P
    Cardiovasc Res; 2008 Jul; 79(1):195-203. PubMed ID: 18339644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.